News
Pfizer’s Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment...
Pfizer Inc announced today that the Japanese Ministry of Health, Labour and Welfare approved Lyrica® (pregabalin) capsules for the treatment of peripheral neuropathic...
News
GlaxoSmithKline receives approval in Japan from the Ministry of...
GlaxoSmithKline announced that it has received approval in Japan from the Ministry of Health, Labour and Welfare for Revolade (eltrombopag) for the treatment of the...
News
Dako and Quintiles form alliance to speed development of...
Dako, a Danish-based world leader in tissue-based cancer diagnostics, and Quintiles, the world’s leading bio pharmaceutical services companies, announced a strategic alliance to advance personalized...
News
PRADAX gains approval in Canada for stroke prevention in...
Health Canada, the Canadian health authority, has approved PRADAX™ (dabigatran etexilate), 1 Boehringer Ingelheim’s novel, oral direct thrombin inhibitor 2 for the prevention of stroke...
News
Significant Milestone for Tengion Clinical Program Currently Enrolling Bladder...
Tengion, Inc., a leader in regenerative medicine, announced that surgeons at the University of Chicago have implanted its Neo-Urinary Conduit(TM) in the first patient as...
News
AstraZeneca initiates phase IIB study for AZD9773 (CytoFab) as...
AstraZeneca announced that it has commenced dosing patients in a global Phase IIb study to compare the efficacy and safety of AZD9773 (CytoFab) with placebo...
News
Cipla launches the world’s first generic Pirfenidone in India
Cipla, among the world's leading generic pharmaceutical companies has introduced Pirfenidone in India; under the brand name Pirfenex, for the treatment of IPF. A chronic...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.